Poolbeg Pharma PLC

OTCPK:POLB.F Stock Report

Market Cap: US$31.9m

Poolbeg Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:POLB.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Feb 25BuyUS$69Davy Global Fund Management LimitedCompany1,148US$0.06
12 Feb 25BuyUS$9,020Davy Global Fund Management LimitedCompany143,914US$0.063
11 Feb 25BuyUS$23Davy Global Fund Management LimitedCompany367US$0.063
10 Feb 25BuyUS$973Davy Global Fund Management LimitedCompany15,278US$0.064
07 Feb 25BuyUS$3,932Davy Global Fund Management LimitedCompany61,677US$0.064
31 Jan 25BuyUS$576Davy Global Fund Management LimitedCompany9,162US$0.063
30 Jan 25SellUS$4,634Davy Global Fund Management LimitedCompany71,501US$0.065
29 Jan 25SellUS$238Davy Global Fund Management LimitedCompany3,680US$0.065
28 Jan 25SellUS$10,536Davy Global Fund Management LimitedCompany152,373US$0.069
27 Jan 25BuyUS$16,029Davy Global Fund Management LimitedCompany240,000US$0.067
27 Jan 25SellUS$0Davy Global Fund Management LimitedCompany136,502US$0.07
23 Jan 25BuyUS$5,579Davy Global Fund Management LimitedCompany93,994US$0.059
23 Jan 25SellUS$2,873Davy Global Fund Management LimitedCompany48,500US$0.059
22 Jan 25BuyUS$29Davy Global Fund Management LimitedCompany503US$0.058
22 Jan 25SellUS$14Davy Global Fund Management LimitedCompany250US$0.058
21 Jan 25BuyUS$154Davy Global Fund Management LimitedCompany2,709US$0.057
17 Jan 25BuyUS$547Davy Global Fund Management LimitedCompany9,977US$0.055
17 Jan 25SellUS$274Davy Global Fund Management LimitedCompany5,000US$0.055
16 Jan 25BuyUS$0Davy Global Fund Management LimitedCompany47,000US$0.057
16 Jan 25SellUS$2,694Davy Global Fund Management LimitedCompany46,855US$0.058

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of POLB.F?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme379,7080.0545%
Public Companies7,494,1061.07%
Private Companies57,855,8518.3%
Individual Insiders95,356,39613.7%
General Public125,482,73818%
Institutions410,631,20158.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 39.4%.

Top Shareholders

Top 25 shareholders own 69.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.1%
Hargreaves Lansdown Asset Management Ltd.
77,197,690US$3.5m18.2%0.01%
5.74%
Roaring Waters Capital Limited
40,000,000US$1.8m0%no data
5.19%
Michael Kelly
36,152,278US$1.7m2%no data
5.05%
Aberdeen Group Plc
35,213,767US$1.6m11%no data
4.78%
Platform Capital Holdings Ltd
33,318,362US$1.5m-4.99%1.22%
3.96%
Shard Capital Partners LLP
27,575,752US$1.3m1,670%2.69%
3.61%
IG Group Holdings plc
25,180,597US$1.2m136%0.07%
3.58%
Cathal Friel
24,964,193US$1.1m-39.4%no data
3.44%
HBOS Investment Fund Managers Limited
23,984,646US$1.1m17%0.01%
2.66%
AIB Group plc
18,526,541US$848.5k4%0.5%
2.48%
Jarvis Securities plc
17,272,212US$791.0k-2.76%0.32%
2.33%
Allan Rankin
16,216,038US$742.7k0%no data
2.11%
Raglan Road Capital Limited
14,702,633US$673.3k5.98%30.35%
1.79%
Barclays Bank PLC
12,452,712US$570.3k8.19%no data
1.64%
Hedley & Company Stockbrokers Ltd.
11,447,454US$524.3k0%0.29%
1.58%
Seneca Partners Limited
11,006,157US$504.1k0%7.8%
1.49%
Dolmen Fund Management
10,417,158US$477.1k23.1%0.17%
1.23%
Dominion Fiduciary Services Limited
8,597,794US$393.8k0%100.0%
1.19%
Ian O'Connell
8,326,839US$381.3k0%no data
1.02%
DEGIRO B.V.
7,078,463US$324.2k6.19%0.08%
0.89%
Patrick Reid
6,192,077US$283.6k0%no data
0.86%
Deutsche Bank Aktiengesellschaft
6,000,000US$274.8k200%no data
0.72%
Sterling Investments Management Limited
5,042,590US$230.9k0%1.5%
0.68%
First Equity Limited
4,710,000US$215.7k104%0.18%
0.67%
UBS Asset Management AG
4,662,807US$213.5k8.21%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/07 14:04
End of Day Share Price 2025/07/10 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Poolbeg Pharma PLC is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adam McCarterCavendish
Brian WhiteShore Capital Group Ltd